Date published: 2026-1-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

LDH-AL6B Activators

These activators might interact with the protein in a way that increases its natural activity, possibly by binding to regulatory sites that stabilize the protein in an active conformation or by facilitating the binding of substrates to the active site. The design of such activators would likely be informed by in-depth structural and functional analyses of the protein, utilizing computational modeling to predict interactions and effects on enzyme kinetics.

To properly characterize and understand the putative "LDH-AL6B Activators," various experimental methodologies would be employed. Biochemical assays would be foundational in determining the effect of these activators on the enzyme's activity, measuring changes in the rate of substrate conversion to product. Kinetic analyses would shed light on the interaction dynamics, revealing whether the activation effect is due to changes in substrate affinity or catalytic turnover rate. Structural studies, such as crystallography or NMR, would provide a visual framework for how these activators interact molecularly with their target protein. Additionally, cell-based assays would contribute to the understanding of the activators' effects in a more complex biological context, elucidating potential alterations in metabolic pathways or other cellular processes linked to the protein's activity. These combined approaches would comprehensively map out the characteristics of these activators, enriching the knowledge of protein function modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cobalt(II) chloride

7646-79-9sc-252623
sc-252623A
5 g
100 g
$64.00
$176.00
7
(1)

Mimics hypoxic conditions that might upregulate metabolic enzymes like LDHAL6B.

Dimethyloxaloylglycine (DMOG)

89464-63-1sc-200755
sc-200755A
sc-200755B
sc-200755C
10 mg
50 mg
100 mg
500 mg
$84.00
$301.00
$374.00
$779.00
25
(2)

Inhibits prolyl hydroxylase, leading to HIF stabilization, which can affect metabolic gene expression.

1,1-Dimethylbiguanide, Hydrochloride

1115-70-4sc-202000F
sc-202000A
sc-202000B
sc-202000C
sc-202000D
sc-202000E
sc-202000
10 mg
5 g
10 g
50 g
100 g
250 g
1 g
$20.00
$43.00
$63.00
$156.00
$260.00
$510.00
$31.00
37
(1)

An AMPK activator that can change metabolic pathways, potentially influencing LDHAL6B expression.

Phenformin Hydrochloride

834-28-6sc-219590
10 g
$119.00
4
(1)

Similar to metformin, it affects cellular metabolism and could hypothetically affect LDHAL6B expression.

Sodium dichloroacetate

2156-56-1sc-203275
sc-203275A
10 g
50 g
$55.00
$209.00
6
(1)

Inhibits pyruvate dehydrogenase kinase, shifting the balance from glycolysis to glucose oxidation, possibly affecting LDHAL6B.

2-Deoxy-D-glucose

154-17-6sc-202010
sc-202010A
1 g
5 g
$70.00
$215.00
26
(2)

A glucose analog that interferes with glycolysis, potentially leading to compensatory mechanisms involving LDHAL6B.

Bufotalin

471-95-4sc-202509
5 mg
$200.00
(0)

Inhibits lactate dehydrogenase activity, which could lead to compensatory upregulation of LDHAL6B.

Pyruvic acid

127-17-3sc-208191
sc-208191A
25 g
100 g
$41.00
$96.00
(0)

As a substrate for LDH enzymes, increased pyruvate levels might upregulate LDHAL6B under certain conditions.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Involved in cell differentiation and may affect the expression of tissue-specific genes like LDHAL6B.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

A glucocorticoid that can influence a wide range of gene expressions, possibly including LDHAL6B.